And much of the company's fate will rest on Spinraza, a new muscular atrophy drug that comes at a steep list price of $ 750,000 for the first year of treatment. (fortune.com)
Once they're off the treatment, once they're finished with treatment, usually we follow these patients more frequently during the first year of treatment. (kidsinthehouse.com)
Biogen, which makes nusinersen, has set the price per injection of nusinersen at $ 125,000, or about $ 750,000 for the first year of treatment. (sciencedaily.com)